HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EPA Would Regulate Nano Materials Under Research Project’s Proposal

This article was originally published in The Tan Sheet

Executive Summary

A report commissioned by the Project on Emerging Nanotechnologies proposes a five-year strategy lawmakers and the Environmental Protection Agency, among others, can follow to create an "intelligent" approach to nanotechnology oversight

You may also be interested in...



Tests Of Nanosilver-Based Consumer Products Needed To Define Risks – PEN

Widespread use in toothpaste and other consumer products of nanosilver - one of the most toxic metals to aquatic organisms - highlights the need for research to better manage the ingredient's environmental and human health risks, according to a new report from the Project on Emerging Nanotechnologies

EPA Asked To Regulate Consumer Items Containing Nano-Silver As Pesticides

A coalition of health and environmental groups led by the International Center for Technology Assessment petitioned the Environmental Protection Agency to halt the sale of products containing nano-size silver and regulate the products as pesticides

Commercialization Phase Brings New Challenges To Nanotech Industry

Increased industry/government collaboration is needed in the field of nanotechnology to move out of the research and development phase and into the commercialization phase, speakers told the President's Council of Advisors on Science and Technology during a June 25 meeting

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS138715

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel